biotechtv.com

Website review biotechtv.com

BiotechTV | Bringing the Biotech Sector to Life

 Generated on April 03 2026 11:12 AM

Old data? UPDATE !

The score is 56/100

SEO Content

Title

BiotechTV | Bringing the Biotech Sector to Life

Length : 47

Perfect, your title contains between 10 and 70 characters.

Description

BiotechTV covers the biotechnology sector with news, stories, and educational videos.

Length : 85

Great, your meta description contains between 70 and 160 characters.

Keywords

Very bad. We haven't found meta keywords on your page. Use this free online meta tags generator to create keywords.

Og Meta Properties

Good, your page take advantage of Og Properties.

Property Content
title BiotechTV
description News, stories, and educational videos about the biotechnology sector.
image https://static.wixstatic.com/media/08e71b_449ffe8e6526438ebdcea22f7e1c1d57~mv2.jpg/v1/fill/w_1200,h_630,al_c/08e71b_449ffe8e6526438ebdcea22f7e1c1d57~mv2.jpg
image:width 1200
image:height 630
url https://www.biotechtv.com
site_name BiotechTV
type website

Headings

H1 H2 H3 H4 H5 H6
5 1 24 35 1 0
  • [H1] Quick Takes
  • [H1] Latest Videos
  • [H1] 2026 SF Healthcare Week
  • [H1] #ASCO25
  • [H1] #ASH25
  • [H2] Join the BiotechTV mailing list
  • [H3] SF Healthcare Week: Perceptive Advisors' Joe Edelman, one of the top investors in biotech, shares his investment philosophy and his take on the sector heading into 2026
  • [H3] SF Healthcare Week: Alnylam CEO Yvonne Greenstreet discusses the launch of Amvuttra in ATTR-CM and the company's new 2030 ambitions | 01/13/26
  • [H3] SF Healthcare Week: Summit Therapeutics has filed for approval on the first indication of its PD1 x VEGF. Will it live up to its promise and set the next standard for cancer care?
  • [H3] Capricor CEO Linda Marbán discusses the eventful year the company had for its DMD treatment deramiocel, including the P3 HOPE-3 readout, and the regulatory filing and review ahead | 01/13/26
  • [H3] SF Healthcare Week: Cytokinetics CEO Robert Blum discusses the approval and impending launch of the cardiomyopathy therapy MYQORZO | 01/16/25
  • [H3] SF Healthcare Week: Sana Bio's CEO Steve Harr describes the science behind the company's cell therapy program that aims to be a cure for type 1 diabetes
  • [H3] SF Healthcare Week: CEO Heather Turner tells us about the neuropsychiatric diseases medicine that enabled LB Pharma to IPO in a tough market last year | 01/15/26
  • [H3] Alumis' CEO Martin Babler walks us through the two successful phase 3 trials the company announced for its TYK2 last week.
  • [H3] ASCO25: Gilead Sciences Chairman & CEO Dan O'Day discusses today's 'practice changing' data for Trodelvy in 1L triple-negative breast cancer, cell therapy, and more in the oncology pipeline | 05/31/25
  • [H3] ASCO 2025: Bicara Therapeutics' CEO Claire Mazumdar discusses the company's EGFR x TGF-β data in head and neck cancer, and compares and contrasts it with a closely watched competitor | 06/01/25
  • [H3] Pfizer Chairman & CEO Dr. Albert Bourla discusses the company's bets on cancer research, VEGF x PD1, #ASCO25 data, and hot button issues affecting the biopharma industry | 05/30/25
  • [H3] ASCO 2025: Instil Bio CEO Bronson Crouch discusses the company's PD1 x VEGF, and shares a quick take on this morning's competitor news | 05/30/25
  • [H3] ASCO 2025: Gilead Sciences' Chairman & CEO Dan O'Day discusses today's 'practice changing' data for Trodelvy in 1L triple-negative breast cancer, cell therapy, and more from the oncology pipeline | 05/31/25
  • [H3] ASCO 2025: Arvinas CEO John Houston discusses the phase 3 study result of the PROTAC Vepdegestrant in breast cancer, the first phase 3 readout of its kind for the field of protein degradation | 06/01/25
  • [H3] ASCO 2025: Arcus Biosciences' CEO Terry Rosen discusses data for the HIF-2a inhibitor Casdatifan in combination with Cabozantinib in kidney cancer | 06/01/25
  • [H3] ASCO 2025: Legend Biotech's CEO Ying Huang discusses new CARVYKTI data at ASCO as well as early stage data for emerging CAR-T targets against solid tumors | 06/01/25
  • [H3] ASH 2025: March Biosciences reported 5 complete responses in all 5 first patients treated in the phase 2 study of its CD5 targeting CAR-T for T-cell lymphoma | 12/8/25
  • [H3] ASH 2025: Nurix CEO Arthur Sands discusses his company's BTK degrader data at ASH, and highlights the benefits of degraders more broadly in oncology and I&I | 12/8/25
  • [H3] ASH 2025: Kelonia Therapeutics presented convincing late-breaking data at ASH today from its initial patients in multiple myeloma suggesting that in vivo CAR-T is on track to be a next innovation | 12/9/25
  • [H3] ASH 2025: Kite Pharma EVP Cindy Perettie discusses today's new data for the pivotal IMMagine-1 study of the BCMA CAR-T, anito-cell. Plus, the future of dual antigen and in vivo CAR-Ts. | 12/6/25
  • [H3] ASH 2025: Kura Oncology CEO Troy Wilson discusses the recent approval of the company's menin inhibitor (KOMZIFTI) in R/R NPM1 mutated AML, and highlights ASH data in the front line setting | 12/8/25
  • [H3] ASH 2025: Disc Medicine CEO John Quisel walks us through the RALLY-MF Phase 2 trial data of DISC-0974 in anemia of myelofibrosis | 12/7/25
  • [H3] ASH 2025: Aleta Biotherapeutics' Paul Rennert shares the company's first clinical data for its CAR-T cell engager program that is meant to increase the density of CD19 on B-cell malignancies. | 12/8/25
  • [H3] ASH 2025: Rigel's CEO Raul Rodriguez discusses the company's IRAK1/4 data in patients with lower-risk MDS | 12/72/25
  • [H4] TOP VIDEO:  State of Possible: Governor Maura Healey discusses state funding initiatives and other ways Massachusetts is trying to support the life sciences sector | 03/26/26
  • [H4] Upcoming Events
  • [H4] Science Spotlight with Chloe Kirk
  • [H4] AI News with Ryan Flinn
  • [H4] Shows
  • [H4] Around Kendall Square
  • [H4] What's new at BiotechTV - from our founder
  • [H4] Follow BiotechTV
  • [H4] Sponsors
  • [H4] Sponsor Spotlight
  • [H4] Get in Touch
  • [H4] Contributors
  • [H4] Advertise: 
  • [H4] News coverage opportunities:
  • [H4] Advertise@BiotechTV.com
  • [H4] MediaOppty@BiotechTV.com
  • [H4] ​
  • [H4] Amy Brown
  • [H4] United Kingdom Area 
  • [H4] Chris Garabedian
  • [H4] BioVenture VoiCes
  • [H4] General equiries and feedback:
  • [H4] Info@BiotechTV.com
  • [H4] Brad Loncar
  • [H4] Founder
  • [H4] Ryan Flinn
  • [H4] AI in Biotech
  • [H4] Join our mail list
  • [H4] Matt Gline
  • [H4] Off-Target Effects
  • [H4] Chloe Kirk
  • [H4] Science Correspondent
  • [H4] Disclosures & Policies
  • [H4] Wassim Laroussi
  • [H4] Markets Correspondent
  • [H5] Out Now: Jonathan Norris' 2025 Full-Year Venture Healthcare Report:  

Images

We found 65 images on this web page.

12 alt attributes are empty or missing. Add alternative text so that search engines can better understand the content of your images.

Text/HTML Ratio

Ratio : 0%

This page's ratio of text to HTML code is below 15 percent, this means that your website probably needs more text content.

Flash

Perfect, no Flash content has been detected on this page.

Iframe

Great, there are no Iframes detected on this page.

URL Rewrite

Good. Your links looks friendly!

Underscores in the URLs

Perfect! No underscores detected in your URLs.

In-page links

We found a total of 0 links including 0 link(s) to files

Anchor Type Juice

SEO Keywords

Keywords Cloud

york page anyone eha2026 new kendall annual meeting june biotech

Keywords Consistency

Keyword Content Title Keywords Description Headings
biotech 3
new 3
meeting 2
kendall 2
york 2

Usability

Url

Domain : biotechtv.com

Length : 13

Favicon

Great, your website has a favicon.

Printability

We could not find a Print-Friendly CSS.

Language

Good. Your declared language is en.

Dublin Core

This page does not take advantage of Dublin Core.

Document

Doctype

HTML 5

Encoding

Perfect. Your declared charset is UTF-8.

W3C Validity

Errors : 0

Warnings : 0

Email Privacy

Warning! At least one email address has been found in the plain text. Use free antispam protector to hide email from spammers.

Deprecated HTML

Great! We haven't found deprecated HTML tags in your HTML.

Speed Tips

Excellent, your website doesn't use nested tables.
Too bad, your website is using inline styles.
Great, your website has few CSS files.
Too bad, your website has too many JS files (more than 6).
Perfect, your website takes advantage of gzip.

Mobile

Mobile Optimization

Apple Icon
Meta Viewport Tag
Flash content

Optimization

XML Sitemap

Great, your website has an XML sitemap.

https://www.biotechtv.com/sitemap.xml

Robots.txt

https://biotechtv.com/robots.txt

Great, your website has a robots.txt file.

Analytics

Missing

We didn't detect an analytics tool installed on this website.

Web analytics let you measure visitor activity on your website. You should have at least one analytics tool installed, but It can also be good to install a second in order to cross-check the data.

PageSpeed Insights

Device
Categories

Free SEO Testing Tool

Free SEO Testing Tool is a free SEO tool which provides you content analysis of the website.